Health FDA Reverses Course, Will Review Moderna’s mRNA Flu Vaccine Application by Dr Natalie Singh - Health Editor February 19, 2026 by Dr Natalie Singh - Health Editor February 19, 2026 FDA Reverses Course, Will Review Moderna’s mRNA Flu Vaccine The U.S. Food and Drug Administration (FDA) will now review Moderna’s novel, messenger RNA (mRNA)-based flu vaccine after reversing its initial … 0 FacebookTwitterPinterestEmail